Le Lézard
Classified in: Health, Science and technology, Business
Subjects: FNC, VEN

Parhelia Biosciences Announces Successful Series A Funding Round


AUSTIN, Texas and ASHLAND, Ore., Oct. 17, 2023 /PRNewswire/ -- Parhelia Biosciences, the leader in sample preparation for tissue staining and spatial analysis, is pleased to announce the successful completion of its Series A financing round. This milestone is a testament to the company's ongoing commitment to providing a single, modular solution for spatial biology sample preparation. 

Parhelia Biosciences is pleased to announce the successful completion of its Series A financing round.

The Series A round saw participation from Rabbit Run Partners, Thielsen Capital, and prominent industry angels. This infusion of capital will accelerate the company's growth, allowing Parhelia Biosciences to expand its robust menu of spatial offerings, scale its support and commercial efforts, and pursue strategic collaborations.

"We're incredibly grateful for the confidence our customers, partners and investors have shown in our vision and our team. This funding will enable us to accelerate the execution of our go-to-market strategy," said Dr. Nikolay Samuisk, Co-founder and CEO of Parhelia Biosciences.

Parhelia Biosciences has made significant strides since its inception, with placements across leading academic institutions and biopharma. 

The Series A funding underscores the market's confidence in Parhelia Biosciences' potential to transform and expand sample preparation for a wide menu of spatial protocols including those already supported ? Phenocycler (formerly CODEX) and Phenoptics (formerly Opal), immunohistochemistry (IHC), hematoxylin and eosin (H&E) staining, RNAScope, immunofluorescence (including CYCIF), and imaging mass cytometry (IMC).

About Parhelia Biosciences:
Parhelia Biosciences is dedicated to providing auto-staining devices that are compact, affordable, flexible, and easy to use for staining automation. Parhelia's co-founders have been part of the Spatial Biology field since its inception and founded the company in 2019 to accelerate the adoption of spatial biology techniques through push-button automation while reducing reagent waste and assay variability.

For more information, visit https://parhelia.bio/ or contact Brandy Lee [email protected].

SOURCE Parhelia Biosciences


These press releases may also interest you

at 04:28
Bulletin from the extraordinary general meeting in SciBase Holding AB (publ)
Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance with the proposals presented in the notice to attend the meeting (which is available on the...

at 03:05
Avata Biosciences Emerges to Develop Solid Dose Cannabinoid Medicines for Epilepsy and Other Neurological Diseases
Avata Biosciences Ltd (?Avata'), the former Sapient Therapeutics, is a clinical-stage biopharmaceutical company with a mission to improve the lives of patients living with neurological diseases. Meaning ?to unlock', Avata is emerging with a new name...

at 03:00
Ecolab and HeiQ introduce synbiotic cleaning products at Interclean
Ecolab and HeiQ Chrisal have teamed up to launch the revolutionary Maxx Synbiotic cleaning range at Interclean in Amsterdam, The Netherlands. ...

at 02:46
Dental Polishing Machine Market to Reach $6.5 Billion Globally by 2032 at 6.1% CAGR: Allied Market Research
Allied Market Research has recently published a report, titled, "Dental Polishing Machine Market Size, Share, Competitive Landscape and Trend Analysis Report by Machine Type, by...

at 02:00
New Research from Self Tan Brand Vita Liberata for Skin Cancer Awareness Month Exposes Serious Health Risks for Women Prioritising a Sunbed Tan Over Wellbeing
Willing to Take the Health Risk. Of 1000 women surveyed: -  1 in 3 use tanning beds and will continue to despite health risks -  91% are aware of the health risks -  Almost half (48%) say sunbeds are addictive Beyond a Tan. The Perceived Benefits by...

at 01:30
XRP Healthcare Solidifies Presence in Uganda with Trademark Registration Success
XRP Healthcare, a pioneering force in healthcare innovation, proudly announces the registration of its trademark in Uganda, marking a significant milestone in its commitment to revolutionize healthcare services in the region. Concurrently, the...

More news about Health...


News published on and distributed by: